litlas
ログインアカウント作成

Michael C. Heinrich

1997–2025 年に発表

167
論文数
47,228
被引用数
102
h 指数
163
i10 指数

被引用数

Michael C. Heinrich の年別被引用数1992 年: 被引用 2 件1996 年: 被引用 3 件1998 年: 被引用 12 件1999 年: 被引用 6 件2000 年: 被引用 11 件2001 年: 被引用 36 件2002 年: 被引用 61 件2003 年: 被引用 240 件2004 年: 被引用 318 件2005 年: 被引用 448 件2006 年: 被引用 481 件2007 年: 被引用 490 件2008 年: 被引用 551 件2009 年: 被引用 643 件2010 年: 被引用 513 件2011 年: 被引用 462 件2012 年: 被引用 473 件2013 年: 被引用 403 件2014 年: 被引用 352 件2015 年: 被引用 296 件2016 年: 被引用 238 件2017 年: 被引用 311 件2018 年: 被引用 227 件2019 年: 被引用 882 件2020 年: 被引用 878 件2021 年: 被引用 1,036 件2022 年: 被引用 759 件2023 年: 被引用 492 件2024 年: 被引用 795 件2025 年: 被引用 227 件2026 年: 被引用 5 件1993〜1995 年は被引用が無いため表示していません1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,072 件、この内訳の 31.8%ドイツ: 引用元論文 635 件、この内訳の 6.6%中国: 引用元論文 622 件、この内訳の 6.4%イタリア: 引用元論文 552 件、この内訳の 5.7%イギリス: 引用元論文 535 件、この内訳の 5.5%フランス: 引用元論文 517 件、この内訳の 5.4%オランダ: 引用元論文 315 件、この内訳の 3.3%日本: 引用元論文 303 件、この内訳の 3.1%カナダ: 引用元論文 265 件、この内訳の 2.7%オーストラリア: 引用元論文 258 件、この内訳の 2.7%スイス: 引用元論文 258 件、この内訳の 2.7%スペイン: 引用元論文 256 件、この内訳の 2.7%
0%31.8%その他 21.4%

機関

分野

  • Medicine70.8%
  • Biochemistry, Genetics and Molecular Biology21.2%
  • Immunology and Microbiology3.8%
  • Computer Science1%
  • Chemistry0.7%
  • Neuroscience0.7%
  • その他1.8%

トピック

  • Gastrointestinal Tumor Research and Treatment6.4%
  • Chronic Myeloid Leukemia Treatments5.9%
  • Sarcoma Diagnosis and Treatment4.2%
  • Chronic Lymphocytic Leukemia Research2.9%
  • Acute Myeloid Leukemia Research2.7%
  • Gastrointestinal disorders and treatments2.5%
  • その他75.4%

共著者

全論文

検索で開く
  1. Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure

    著者: Timothy P. Hughes, Michael J. Mauro, Jörge E. Cortes, Hironobu Minami, Delphine Réa, Daniel J. DeAngelo, Massimo Breccia, Yeow-Tee Goh, Moshe Talpaz, Andreas Hochhaus, Philipp le Coutre, Oliver G. Ottmann, Michael C. Heinrich, Juan Luis Steegmann, Michael W. Deininger, Jeroen J. W. M. Janssen, François-Xavier Mahon, Yosuke Minami, David T Yeung, David M. Ross, Martin S. Tallman, Jae H. Park, Brian Druker, David Hynds, Yuyan Duan, Christophe Meille, Florence Hourcade‐Potelleret, K. Gary J. Vanasse, Fabian Lang, Dong‐Wook Kim - New England Journal of Medicine 2019 被引用: 467

  2. Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors

    著者: George D. Demetri, Margaret von Mehren, Charles D. Blanke, Annick D. Van den Abbeele, Burton Eisenberg, Peter Roberts‎, Michael C. Heinrich, David A. Tuveson, Samuel Singer, Milos J. Janicek, Jonathan A. Fletcher, Stuart G. Silverman, Sandra Silberman, Renaud Capdeville, Beate Kiese, Bin Peng, Saša Dimitrijević, Brian Druker, Christopher L. Corless, Christopher D.�M. Fletcher, Heikki Joensuu - New England Journal of Medicine 2002 被引用: 4,389

  3. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

    著者: George D. Demetri, Allan T. van Oosterom, Christopher R. Garrett, Martin E. Blackstein, Manisha H. Shah, Jaap Verweij, Grant A. McArthur, Ian Judson, Michael C. Heinrich, Jeffrey A. Morgan, Jayesh Desai, Christopher D.�M. Fletcher, Suzanne George, Carlo L. Bello, Xin Huang, Charles M. Baum, Paolo G. Casali - The Lancet 2006 被引用: 2,595

  4. Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants

    著者: Christopher A. Eide, Matthew S. Zabriskie, Samantha L. Savage, Orlando Antelope, Nadeem A. Vellore, Hein Than, Anna Reister Schultz, Phillip M. Clair, Amber D. Bowler, Anthony D. Pomicter, Dongqing Yan, Anna V. Senina, Qiang Wang, Todd W. Kelley, Philippe Szankasi, Michael C. Heinrich, Jeffrey Tyner, Delphine Réa, Jean-Michel Cayuela, Dong‐Wook Kim, Cristina E. Tognon, Thomas O’Hare, Brian Druker, Michael W. Deininger - Cancer Cell 2019 被引用: 245

  5. PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors

    著者: Michael C. Heinrich, Christopher L. Corless, Anette Duensing, Laura McGreevey, Chang-Jie Chen, Nora Joseph, Samuel Singer, Diana Griffith, Andrea Haley, Ajia Town, George D. Demetri, Christopher D.�M. Fletcher, Jonathan A. Fletcher - Science 2003 被引用: 2,302

  6. Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial

    著者: Michael C. Heinrich, Robin L. Jones, Margaret von Mehren, Patrick Schöffski, César Serrano, Yoon‐Koo Kang, Philippe A. Cassier, Olivier Mir, Ferry A.L.M. Eskens, William D. Tap, Piotr Rutkowski, Sant P. Chawla, Jonathan C. Trent, Meera Tugnait, Erica N Evans, Tamieka Lauz, Teresa Zhou, Maria Roche, Beni B. Wolf, Sebastian Bauer, Suzanne George - The Lancet Oncology 2020 被引用: 304

  7. Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial

    著者: Jean‐Yves Blay, César Serrano, Michael C. Heinrich, John Zalcberg, Sebastian Bauer, Hans Gelderblom, Patrick Schöffski, Robin L. Jones, Steven Attia, Gina Z. D’Amato, Ping Chi, Peter Reichardt, Julie Meade, Kelvin Shi, Rodrigo Ruiz‐Soto, Suzanne George, Margaret von Mehren - The Lancet Oncology 2020 被引用: 407

  8. Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants

    著者: Bryan D. Smith, Michael D. Kaufman, Wei-Ping Lu, Anu Gupta, Cynthia B. Leary, Scott Wise, Thomas J. Rutkoski, Yu Mi Ahn, Gada Al-Ani, Stacie L. Bulfer, Timothy M. Caldwell, Lawrence Chun, Carol L. Ensinger, Molly M. Hood, Arin McKinley, William C. Patt, Rodrigo Ruiz‐Soto, Ying Su, Hanumaiah Telikepalli, Ajia Town, Benjamin A. Turner, Lakshminarayana Vogeti, Subha Vogeti, Karen Yates, Filip Jankú, Albiruni Ryan Abdul Razak, Oliver Rosen, Michael C. Heinrich, Daniel L. Flynn - Cancer Cell 2019 被引用: 277

  9. Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin

    著者: F. Stephen Hodi, Christopher L. Corless, Anita Giobbie‐Hurder, Jonathan A. Fletcher, Mei‐Jun Zhu, Adrián Mariño‐Enríquez, Philip Friedlander, René González, Jeffrey S. Weber, Thomas F. Gajewski, Steven O’Day, Kevin B. Kim, Donald P. Lawrence, Keith T. Flaherty, Jason J. Luke, Frances A. Collichio, Marc S. Ernstoff, Michael C. Heinrich, Carol Beadling, Katherine Zukotynski, Jeffrey T. Yap, Annick D. Van den Abbeele, George D. Demetri, David E. Fisher - Journal of Clinical Oncology 2013 被引用: 595

  10. Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor

    著者: Michael C. Heinrich, Christopher L. Corless, George D. Demetri, Charles D. Blanke, Margaret von Mehren, Heikki Joensuu, Laura McGreevey, Changjie Chen, Annick D. Van den Abbeele, Brian Druker, Beate Kiese, Burton Eisenberg, Peter Roberts‎, Samuel Singer, Christopher D.�M. Fletcher, Sandra Silberman, Saša Dimitrijević, Jonathan A. Fletcher - Journal of Clinical Oncology 2003 被引用: 2,297

  11. Gastrointestinal stromal tumours: origin and molecular oncology

    著者: Christopher L. Corless, Christine M. Barnett, Michael C. Heinrich - Nature reviews. Cancer 2011 被引用: 887

  12. New treatment strategies for advanced-stage gastrointestinal stromal tumours

    著者: Lillian R. Klug, Homma M. Khosroyani, Jason D. Kent, Michael C. Heinrich - Nature Reviews Clinical Oncology 2022 被引用: 130

  13. Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial

    著者: Sebastian Bauer, Robin L. Jones, Jean‐Yves Blay, Hans Gelderblom, Suzanne George, Patrick Schöffski, Margaret von Mehren, John Zalcberg, Yoon‐Koo Kang, Albiruni Abdul Razak, Jonathan C. Trent, Steven Attia, Axel Le Cesne, Ying Su, Julie Meade, Tao Wang, Matthew L. Sherman, Rodrigo Ruiz‐Soto, Michael C. Heinrich - Journal of Clinical Oncology 2022 被引用: 111

  14. Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results

    著者: Michael J. Mauro, Timothy P. Hughes, Dong‐Wook Kim, Delphine Réa, Jörge E. Cortes, Andreas Hochhaus, Koji Sasaki, Massimo Breccia, Moshe Talpaz, Oliver G. Ottmann, Hironobu Minami, Yeow Tee Goh, Daniel J. DeAngelo, Michael C. Heinrich, Valle Gómez-Garcı́a de Soria, Philipp le Coutre, François‐Xavier Mahon, Jeroen J. W. M. Janssen, Michael W. Deininger, Naranie Shanmuganathan, Mark B. Geyer, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Matthias Hoch, Fabian Lang - Leukemia 2023 被引用: 47

  15. Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

    著者: César Serrano, Adrián Mariño‐Enríquez, Derrick L. Tao, Julia Ketzer, Grant Eilers, Mei‐Jun Zhu, Channing Yu, Aristotle M. Mannan, Brian P. Rubin, George D. Demetri, Chandrajit P. Raut, Ajia Presnell, Arin McKinley, Michael C. Heinrich, Jeffrey T. Czaplinski, Ewa Sicińska, Sebastian Bauer, Suzanne George, Jonathan A. Fletcher - British Journal of Cancer 2019 被引用: 166

  16. PDGFRA Mutations in Gastrointestinal Stromal Tumors: Frequency, Spectrum and In Vitro Sensitivity to Imatinib

    著者: Christopher L. Corless, Arin Schroeder, Diana Griffith, Ajia Town, Laura McGreevey, Patina M. Harrell, Sharon Shiraga, Troy Bainbridge, Jason R. Morich, Michael C. Heinrich - Journal of Clinical Oncology 2005 被引用: 838

  17. The contemporary management of cancers of the sinonasal tract in adults

    著者: Rajat Thawani, Myung Sun Kim, Asad Arastu, Zizhen Feng, Malinda West, Nicholas Taflin, Kyaw Zin Thein, Ryan Li, Mathew Geltzeiler, Nancy Y. Lee, Clifton D. Fuller, Jennifer R. Grandis, Charalampos S. Floudas, Michael C. Heinrich, Ehab Hanna, Ravi A. Chandra - CA A Cancer Journal for Clinicians 2022 被引用: 118

  18. Heterogeneity of kinase inhibitor resistance mechanisms in GIST

    著者: Bernadette Liegl, Ilana Kepten, Claudia Le, Mei‐Jun Zhu, George D. Demetri, Michael C. Heinrich, CDM Fletcher, Christopher L. Corless, JA Fletcher - The Journal of Pathology 2008 被引用: 455

  19. FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors

    著者: Eileen Shi, Juliann Chmielecki, Chih‐Min Tang, Kai Wang, Michael C. Heinrich, Guhyun Kang, Christopher L. Corless, David S. Hong, Katherine E. Fero, James D. Murphy, Paul T. Fanta, Siraj M. Ali, Martina De Siena, Adam M. Burgoyne, Sujana Movva, Lisa Madlensky, Gregory M. Heestand, Jonathan C. Trent, Razelle Kurzrock, Deborah Morosini, Jeffrey S. Ross, Olivier Harismendy, Jason K. Sicklick - Journal of Translational Medicine 2016 被引用: 233

  20. Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis

    著者: Hyunho Yoon, Chih-Min Tang, Sudeep Banerjee, Mayra Yebra, Sangkyu Noh, Adam M. Burgoyne, Jorge de la Torre, Martina De Siena, Mengyuan Liu, Lillian R. Klug, Yoon Young Choi, Mojgan Hosseini, Antonio L. Delgado, Zhiyong Wang, Randall P. French, Andrew M. Lowy, Ronald P. DeMatteo, Michael C. Heinrich, Alfredo Molinolo, J. Silvio Gutkind, Olivier Harismendy, Jason K. Sicklick - Oncogene 2021 被引用: 54

  21. Gastrointestinal stromal tumour

    著者: Brian P. Rubin, Michael C. Heinrich, Christopher L. Corless - The Lancet 2007 被引用: 1,043

  22. In vitro Activity of Bcr-Abl Inhibitors AMN107 and BMS-354825 against Clinically Relevant Imatinib-Resistant Abl Kinase Domain Mutants

    著者: Thomas O’Hare, Denise K. Walters, Eric P. Stoffregen, Taiping Jia, Paul W. Manley, Jürgen Mestan, Sandra W. Cowan‐Jacob, Francis Y. Lee, Michael C. Heinrich, Michael W. Deininger, Brian Druker - Cancer Research 2005 被引用: 1,034

  23. KIT Gene Mutations and Copy Number in Melanoma Subtypes

    著者: Carol Beadling, Erick Jacobson‐Dunlop, F. Stephen Hodi, Claudia Le, Andrea Warrick, Janice Patterson, Ajia Town, Amy Harlow, Frank Cruz, Sharl Azar, Brian P. Rubin, Susan Müller, Robert B. West, Michael C. Heinrich, Christopher L. Corless - Clinical Cancer Research 2008 被引用: 636

  24. Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study

    著者: Yoon‐Koo Kang, Suzanne George, Robin L. Jones, Piotr Rutkowski, Lin Shen, Olivier Mir, Shreyaskumar Patel, Yongjian Zhou, Margaret von Mehren, Peter Hohenberger, Víctor M. Villalobos, Mehdi Brahmi, William D. Tap, Jonathan C. Trent, Maria A. Pantaleo, Patrick Schöffski, Kevin He, Paggy Hew, Kate J. Newberry, Maria Roche, Michael C. Heinrich, Sebastian Bauer - Journal of Clinical Oncology 2021 被引用: 116